Chronic Myeloproliferative Disorders
Showing NaN - NaN of 10
Healthy Volunteers of Fanconi Anemia, Myeloproliferative
Completed
- Chronic Myeloproliferative Disorders
- +3 more
- microarray analysis
- +8 more
-
Portland, OregonKnight Cancer Institute at Oregon Health and Science University
Jun 30, 2022
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Portland (biological, drug, procedure, radiation)
Terminated
- Chronic Myeloproliferative Disorders
- +6 more
- anti-thymocyte globulin
- +16 more
-
Portland, OregonOHSU Knight Cancer Institute
Sep 25, 2017
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Portland (biological, drug, procedure, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- therapeutic allogeneic lymphocytes
- +9 more
-
Portland, OregonKnight Cancer Institute at Oregon Health and Science University
Sep 25, 2017
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (baclofen/amitriptyline/ketamine gel, )
Completed
- Chronic Myeloproliferative Disorders
- +9 more
- baclofen/amitriptyline/ketamine gel
- placebo
-
Scottsdale, Arizona
- +164 more
Jul 25, 2017
Blood Samples From Patients onClinical Trial to CINV During HSCT
Terminated
- Breast Cancer
- +11 more
- immunoenzyme technique
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
May 7, 2017
Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Portland (moxifloxacin HCl, Placebo)
Terminated
- Breast Cancer
- +11 more
- moxifloxacin hydrochloride
- Placebo
-
Portland, OregonKnight Cancer Institute at Oregon Health and Science University
May 7, 2017
Chronic Myeloproliferative Disorders, Fatigue, Leukemia Trial in United States (American ginseng, )
Completed
- Chronic Myeloproliferative Disorders
- +9 more
- American ginseng
- placebo
-
Scottsdale, Arizona
- +325 more
Dec 19, 2016
Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- ruxolitinib phosphate
- +2 more
-
Birmingham, Alabama
- +23 more
Oct 22, 2014
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Portland (biological, drug, procedure, radiation)
Terminated
- Chronic Myeloproliferative Disorders
- +7 more
- filgrastim
- +7 more
-
Portland, OregonOHSU Knight Cancer Institute
May 24, 2012
Chronic Myeloproliferative Disorders Trial in Portland (imatinib mesylate)
Terminated
- Chronic Myeloproliferative Disorders
- imatinib mesylate
-
Portland, OregonOHSU Knight Cancer Institute
Dec 1, 2011